FREE PREMIUM SUBSCRIPTION FOR 14 DAYS!

CASI Pharmaceuticals Stock Forecast NASDAQ:CASI

Price Target and Analyst Ratings

Most Recent Rating

BTIG Research is very positive about CASI and gave it a "Buy" rating on May 24, 2021. The price target was set to $4.00.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-05-24 Buy Initiated by BTIG Research $1.63 $4.00
2021-05-20 Buy Target Raised by HC Wainwright $1.53 $3.50 → $4.00
2021-05-17 Buy Initiated by BTIG Research $1.44 $4.00
2021-05-17 Buy Initiated by BTIG Research $1.44
2021-05-14 Buy Target Raised by HC Wainwright $1.45 $3.50 → $4.00
2021-05-03 Buy Initiated by Mizuho $1.75 $3.80
2021-04-26 Buy Initiated by Mizuho $1.83 $3.80
2020-11-10 Buy Reiterated by Oppenheimer $2.00 $5.00
2020-10-23 Outperform Initiated by Oppenheimer $1.77

CASI Stock Trend

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.10 is broken, it will firstly indicate a stronger fall rate.

Given the current short-term trend, the stock is expected to fall -19.75% during the next 3 months and, with a 90% probability hold a price between $0.88 and $1.21 at the end of this 3-month period.

Data

Date Bottom Mid Top
2021-08-03 $1.09 $1.30 $1.51
2021-08-04 $1.08 $1.29 $1.50
2021-08-05 $1.08 $1.29 $1.49
2021-08-06 $1.07 $1.28 $1.49
2021-08-09 $1.07 $1.27 $1.48
2021-08-10 $1.06 $1.27 $1.48
2021-08-11 $1.05 $1.26 $1.47
2021-08-12 $1.05 $1.26 $1.46
2021-08-13 $1.04 $1.25 $1.46
2021-08-16 $1.04 $1.24 $1.45
2021-08-17 $1.03 $1.24 $1.45
2021-08-18 $1.02 $1.23 $1.44
2021-08-19 $1.02 $1.23 $1.43
2021-08-20 $1.01 $1.22 $1.43
2021-08-23 $1.01 $1.21 $1.42
2021-08-24 $1.00 $1.21 $1.42
2021-08-25 $0.99 $1.20 $1.41
2021-08-26 $0.99 $1.20 $1.40
2021-08-27 $0.98 $1.19 $1.40
2021-08-30 $0.98 $1.18 $1.39
2021-08-31 $0.97 $1.18 $1.39
2021-09-01 $0.96 $1.17 $1.38
2021-09-02 $0.96 $1.17 $1.37
2021-09-03 $0.95 $1.16 $1.37
2021-09-07 $0.95 $1.15 $1.36
2021-09-08 $0.94 $1.15 $1.36
2021-09-09 $0.93 $1.14 $1.35
2021-09-10 $0.93 $1.14 $1.34
2021-09-13 $0.92 $1.13 $1.34
2021-09-14 $0.92 $1.12 $1.33

About CASI Pharmaceuticals

CASI Pharmaceuticals, Inc., a late-stage biopharmaceutical company, acquires, develops, and commercializes therapeutics addressing cancer and other unmet medical needs in China. Its lead drug candidate is ENMD-2076, an Aurora A and angiogenic kinase inhibitor, which is in multiple Phase II studies in advanced fibrolamellar carcinoma, triple-negative breast cancer, advanced ovarian clear cell carcinomas, and advanced/metastatic soft tissue sarcoma... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT